M

Metagenomi Inc
NASDAQ:MGX

Watchlist Manager
Metagenomi Inc
NASDAQ:MGX
Watchlist
Price: 4.05 USD 4.92% Market Closed
Market Cap: 151.6m USD
Have any thoughts about
Metagenomi Inc?
Write Note

Intrinsic Value

MGX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MGX stock under the Base Case scenario is 3.83 USD. Compared to the current market price of 4.05 USD, Metagenomi Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MGX Intrinsic Value
3.83 USD
Overvaluation 6%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Metagenomi Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MGX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MGX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MGX?
Bearish
Neutral
Bullish

Fundamental Analysis

4.05 USD
+4.92%
+4.92%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Metagenomi Inc
US
Biotechnology
Market Cap
151.6m USD
IPO
Feb 9, 2024
Employees
223
United States of America
Market Cap
151.6m USD
Industry
Biotechnology
IPO
Feb 9, 2024
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Metagenomi Inc

Provide an overview of the primary business activities
of Metagenomi Inc.

What unique competitive advantages
does Metagenomi Inc hold over its rivals?

What risks and challenges
does Metagenomi Inc face in the near future?

Has there been any significant insider trading activity
in Metagenomi Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Metagenomi Inc.

Provide P/S
for Metagenomi Inc.

Provide P/E
for Metagenomi Inc.

Provide P/OCF
for Metagenomi Inc.

Provide P/FCFE
for Metagenomi Inc.

Provide P/B
for Metagenomi Inc.

Provide EV/S
for Metagenomi Inc.

Provide EV/GP
for Metagenomi Inc.

Provide EV/EBITDA
for Metagenomi Inc.

Provide EV/EBIT
for Metagenomi Inc.

Provide EV/OCF
for Metagenomi Inc.

Provide EV/FCFF
for Metagenomi Inc.

Provide EV/IC
for Metagenomi Inc.

Show me price targets
for Metagenomi Inc made by professional analysts.

What are the Revenue projections
for Metagenomi Inc?

How accurate were the past Revenue estimates
for Metagenomi Inc?

What are the Net Income projections
for Metagenomi Inc?

How accurate were the past Net Income estimates
for Metagenomi Inc?

What are the EPS projections
for Metagenomi Inc?

How accurate were the past EPS estimates
for Metagenomi Inc?

What are the EBIT projections
for Metagenomi Inc?

How accurate were the past EBIT estimates
for Metagenomi Inc?

Compare the revenue forecasts
for Metagenomi Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Metagenomi Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Metagenomi Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Metagenomi Inc compared to its peers.

Compare the P/E ratios
of Metagenomi Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Metagenomi Inc with its peers.

Analyze the financial leverage
of Metagenomi Inc compared to its main competitors.

Show all profitability ratios
for Metagenomi Inc.

Provide ROE
for Metagenomi Inc.

Provide ROA
for Metagenomi Inc.

Provide ROIC
for Metagenomi Inc.

Provide ROCE
for Metagenomi Inc.

Provide Gross Margin
for Metagenomi Inc.

Provide Operating Margin
for Metagenomi Inc.

Provide Net Margin
for Metagenomi Inc.

Provide FCF Margin
for Metagenomi Inc.

Show all solvency ratios
for Metagenomi Inc.

Provide D/E Ratio
for Metagenomi Inc.

Provide D/A Ratio
for Metagenomi Inc.

Provide Interest Coverage Ratio
for Metagenomi Inc.

Provide Altman Z-Score Ratio
for Metagenomi Inc.

Provide Quick Ratio
for Metagenomi Inc.

Provide Current Ratio
for Metagenomi Inc.

Provide Cash Ratio
for Metagenomi Inc.

What is the historical Revenue growth
over the last 5 years for Metagenomi Inc?

What is the historical Net Income growth
over the last 5 years for Metagenomi Inc?

What is the current Free Cash Flow
of Metagenomi Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Metagenomi Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Metagenomi Inc

Balance Sheet Decomposition
Metagenomi Inc

Current Assets 282.3m
Cash & Short-Term Investments 274.6m
Receivables 589k
Other Current Assets 7.1m
Non-Current Assets 76.1m
Long-Term Investments 10.6m
PP&E 59.9m
Other Non-Current Assets 5.6m
Current Liabilities 45.7m
Accounts Payable 3.1m
Accrued Liabilities 13.5m
Other Current Liabilities 29.1m
Non-Current Liabilities 56.9m
Other Non-Current Liabilities 56.9m
Efficiency

Earnings Waterfall
Metagenomi Inc

Revenue
55.1m USD
Operating Expenses
-143.6m USD
Operating Income
-88.5m USD
Other Expenses
14.5m USD
Net Income
-74m USD

Free Cash Flow Analysis
Metagenomi Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MGX Profitability Score
Profitability Due Diligence

Metagenomi Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Positive 1-Year Revenue Growth
Negative Revenue Growth Forecast
Negative Operating Income
Negative Net Income
19/100
Profitability
Score

Metagenomi Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

MGX Solvency Score
Solvency Due Diligence

Metagenomi Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
59/100
Solvency
Score

Metagenomi Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MGX Price Targets Summary
Metagenomi Inc

Wall Street analysts forecast MGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MGX is 18.77 USD with a low forecast of 14.14 USD and a high forecast of 26.25 USD.

Lowest
Price Target
14.14 USD
249% Upside
Average
Price Target
18.77 USD
363% Upside
Highest
Price Target
26.25 USD
548% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MGX?

Click here to dive deeper.

Dividends

Metagenomi Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MGX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MGX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MGX stock?

The intrinsic value of one MGX stock under the Base Case scenario is 3.83 USD.

Is MGX stock undervalued or overvalued?

Compared to the current market price of 4.05 USD, Metagenomi Inc is Overvalued by 6%.

Back to Top